Sort
48,018 grants matching “immunotherapy”
Southeast Pediatric AIDS Clinical Trials Unit
$706,138University Of Alabama At Birmingham · U01 · FY2004 · AI
Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy
$706,097Sonia Sharma · La Jolla Institute For Immunology · R01 · FY2023 · CA
Regulation of CTCF Functions and Target Sites by Cancer/Testis-specific CTCF Like BORIS Factor
$706,093Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
TLR5 enhancement of liver-directed radiotherapy plus immune checkpoint blockade against irradiated liver metastasis and abscopal tumors
$705,888Craig M. Brackett · Roswell Park Cancer Institute Corp · R01 · FY2025 · CA
Endothelial Injury, BMPR2 Dysfunction and Macrophage Activation Cause EndMT and PAH
$705,629Marlene Rabinovitch · Stanford University · R01 · FY2020 · HL
Outcomes for CLL patients treated with novel therapy
$705,542Neil E Kay · Mayo Clinic Rochester · R01 · FY2021 · CA
CORE C Technology Implementation/Development and Correlative Sciences
$705,526Friederike Herbst-Nowrouzi · University Of Pennsylvania · P01 · FY2025 · CA
Identifying and modulating pathologic T cells that govern oral mucosal immune related adverse events from immune checkpoint blockade
$705,441Rajan P. Kulkarni · Oregon Health & Science University · R01 · FY2024 · DE
Redox Mechanism Process of Angiogenesis and Wound Healing
$705,416David Wink · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Baltimore Acute Hepatitis C Cooperative Center
$705,407Andrea L Cox · Johns Hopkins University · U19 · FY2013 · AI
Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma
$705,167Xiuli Wang · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
DEVELOPMENT OF GUAR-T AS A NOVEL CLASS OF UNIVERSAL CELLULAR IMMUNOTHERAPIES FOR OVARIAN CANCER
$705,038Yale Univ · · FY2025 · Defense Health Agency
Yale Autoimmunity Center of Excellence
$704,980Kevan C Herold · Yale University · U19 · FY2012 · AI
COOPERATIVE CLINICAL TRIALS IN ADULT TRANSPLANTATION
$704,879University Of Minnesota Twin Cities · U01 · FY2000 · AI
Examining IL-15 as an immunotherapy agent in cancer and AIDS
$704,873Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
IMPACT OF TUBERCULOSIS OF HIV INFECTION IN UGANDA
$704,793Case Western Reserve University · R01 · FY2000 · AI
Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancer
$704,749David P Carbone · Ohio State University · R01 · FY2024 · CA
Development of a platform for spatial functional genomics
$704,657Brian D Brown · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · AT
A Novel Synthetically Engineered Oral Immunotherapy for Treating Ulcerative Colitis
$704,565Gary Fanger · Rise Therapeutics, Llc · SB1 · FY2025 · DK
Probing cytosolic nucleic acid sensing pathways in cancer
$704,556Ashley Marie Laughney · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Probing cytosolic nucleic acid sensing pathways in cancer
$704,556Ashley Marie Laughney · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA
Immune correlates of acute HBV recovery with and without HIV
$704,503Chloe L Thio · Johns Hopkins University · R01 · FY2015 · AI
Basic Research Support for the CCR
$704,435Thomas A Misteli · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Leveraging fructose transport to create a privileged substrate to selectively fuel T cells
$704,431Kayvan R Keshari · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
T-cell intrinsic mechanisms of resistance to PD-1 checkpoint blockade
$704,403Michelle Krogsgaard · New York University School Of Medicine · R01 · FY2020 · CA